Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel activators and small-molecule inhibitors of STAT3 in cancer
Lehe Yang, Shichong Lin, Lingyuan Xu, et al.
Cytokine & Growth Factor Reviews (2019) Vol. 49, pp. 10-22
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen, Natasha K. Brockwell, Belinda S. Parker
Cancers (2019) Vol. 11, Iss. 12, pp. 2002-2002
Open Access | Times Cited: 531
Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases
Alessia Capone, Elisabetta Volpe
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 140
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4213-4213
Open Access | Times Cited: 128
Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
Ajaz A. Bhat, Sabah Nisar, Selma Maacha, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 109
Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Cells (2020) Vol. 9, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 108
Contribution of STAT3 to the pathogenesis of COVID-19
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
Microbial Pathogenesis (2021) Vol. 154, pp. 104836-104836
Open Access | Times Cited: 83
Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights
Nouf Juaid, Amr Amin, Ali Abdalla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10774-10774
Open Access | Times Cited: 83
Radiation Resistance: A Matter of Transcription Factors
Chiara Galeaz, Cristina Totis, Alessandra Bisio
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 78
Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers
Le Zhang, Cuixia Li, Xiulan Su
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 77
Anticancer Potential of the Plant‐Derived Saponin Gracillin: A Comprehensive Review of Mechanistic Approaches
Md. Shimul Bhuia, Raihan Chowdhury, Fatema Akter Sonia, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 34
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
Sunanda Singh, Héctor W. Gómez, Shreya Thakkar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4722-4722
Open Access | Times Cited: 23
Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities
Heba A. Elsebaie, Tarek F. El‐Moselhy, Eman A. El-Bastawissy, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107101-107101
Closed Access | Times Cited: 15
Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments
Heba A. Elsebaie, Maha-Hamadien Abdulla, Zainab M. Elsayed, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107626-107626
Closed Access | Times Cited: 8
STAT3 Activation and Oncogenesis in Lymphoma
Fen Zhu, Kevin Boyang Wang, Lixin Rui
Cancers (2019) Vol. 12, Iss. 1, pp. 19-19
Open Access | Times Cited: 68
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy
Sruthi V. Hindupur, Sebastian C. Schmid, J. Koch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1106-1106
Open Access | Times Cited: 56
Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells
Scott J. Sauer, Damon R. Reed, Michael A. Ihnat, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 46
Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition.
Ying Bai, Xuye Wang, Mengsi Cai, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 1, pp. 200-214
Closed Access | Times Cited: 42
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
Junqing Gan, Shan Liu, Yu Zhang, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 8, pp. 1290-1305
Open Access | Times Cited: 35
Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies
Satish Kumar Vemuri, Satyajit Halder, Rajkiran Reddy Banala, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2150-2150
Open Access | Times Cited: 33
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 20
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors
Shanthi Ganesh, Min Ju Kim, Jenny Lee, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1895-1916
Open Access | Times Cited: 6
Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia
Antonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 49
Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway
Lehe Yang, Feng Zhou, Yan Zhuang, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 3, pp. 645-657
Open Access | Times Cited: 46
On Broken Ne(c)ks and Broken DNA: The Role of Human NEKs in the DNA Damage Response
Isadora Carolina Betim Pavan, Andressa Peres de Oliveira, Pedro Rafael F Dias, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 507-507
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top